Core Insights - The latest net value of GF Healthcare Stock A (004851) is 2.0674 CNY, reflecting a decrease of 1.09% [1] - The fund has shown a one-month return of 0.67%, ranking 443 out of 455 in its category; a six-month return of 27.59%, ranking 63 out of 441; and a year-to-date return of 27.90%, ranking 137 out of 441 [1] Fund Holdings - The top ten holdings of GF Healthcare Stock A account for a total of 50.56%, with the largest positions being: - Zai Lab Ltd (9.36%) - Kelun Pharmaceutical (8.62%) - Baillie Gifford (7.47%) - XinNuoWei (4.61%) - Hansoh Pharmaceutical (4.45%) - WuXi AppTec (4.07%) - Dong-E E-Jiao (3.07%) - BeiGene Ltd (3.07%) - KAILI Medical (3.01%) - Huatai Medical (2.83%) [1] Fund Overview - GF Healthcare Stock A was established on August 10, 2017, and as of June 30, 2025, it has a total scale of 5.247 billion CNY [1] - The fund manager is Wu Xingwu, who has extensive experience in the investment management field [2]
8月20日广发医疗保健股票A净值下跌1.09%，近1个月累计上涨0.67%
Sou Hu Cai Jing·2025-08-20 12:13